A Korean research team jointly led by Professor Chan Beum Park of the Materials Science and Engineering Department at KAIST and Dr. Kwon Yu from the Bionano Center at the Korea Research Institute of Bioscience and Biotechnology (KRIBB) conducted research to suppress an abnormal assembly of beta-amyloids, a protein commonly found in the brain, by using photo-excited porphyrins.
Beta-amyloid plaques are known to cause Alzheimer’s disease. This research finding suggests new ways to treat neurodegenerative illnesses including Alzheimer’s disease. It was published online as the lead article in the September 21th issue of Angewandte Chemie. The title of the article is “Photo-excited Porphyrins as a Strong Suppressor of ß-Amyloid Aggregation and Synaptic Toxicity.”
Light-induced treatments using organic photosensitizers have advantages to managing the treatment in time and area. In the case of cancer treatments, doctors use photodynamic therapies where a patient is injected with an organic photosensitizer, and a light is shed on the patient’s lesion. However, such therapies had never been employed to treat neurodegenerative diseases.
Alzheimer’s starts when a protein called beta-amyloid is created and deposited in a patient’s brain. The abnormally folded protein created this way harms the brain cells by inducing the degradation of brain functions, for example, dementia. If beta-amyloid creation can be suppressed at an early stage, the formation of amyloid deposits will stop. This could prevent Alzheimer’s disease or halt its progress.
The research team effectively prevented the buildup of beta-amyloids by using blue LED lights and a porphyrin inducer, which is a biocompatible organic compound. By absorbing light energy, a photosensitizer such as porphyrin reaches the excitation state. Active oxygen is created as the porphyrin returns to its ground state. The active oxygen oxidizes a beta-amyloid monomer, and by combining with it, disturbs its assembly.
The technique was tested on drosophilae or fruit flies, which were produced to model Alzheimer on invertebrates. The research showed that symptoms of Alzheimer’s disease in the fruit flies such as damage on synapse and muscle, neuronal apoptosis, degradation in motility, and decreased longevity were alleviated. Treatments with light provide additional benefits: less medication is needed than other drug treatments, and there are fewer side effects. When developed, photodynamic therapy will be used widely for this reason.
Professor Park said,
“This work has significance as it was the first case to use light and photosensitizers to stop deposits of beta-amyloids. We plan to carry the research further by testing compatibility with other organic and inorganic photosensitizers and by changing the subject of photodynamic therapy to vertebrate such as mice.”
Read more: Using Light to Treat Alzheimer’s Disease
The Latest on: Photodynamic therapy
via Google News
The Latest on: Photodynamic therapy
- Scientists explore using nanoparticles to reduce size of deep-seated tumorson September 6, 2019 at 1:45 am
Wei Chen, in collaboration with colleagues from the University of Rhode Island and Brown University, recently published a new paper in the Proceedings of the National Academy of Sciences journal ...
- Scientist explores using nanoparticles to reduce size of deep-seated tumorson September 6, 2019 at 12:16 am
"Traditional nanoparticles used for photodynamic therapy can only be activated by light that is not highly penetrating, meaning we're limited with how deep we can go to target tumors," said Chen ...
- UTA scientist explores using nanoparticles to reduce size of deep-seated tumorson September 5, 2019 at 2:15 pm
The project continues Chen's work developing photosensitizer nanoparticles for use in photodynamic therapy, a promising cancer treatment method that activates reactive oxygen species to kill cancer ...
- Theralase Annouces First Patient Treated in Phase II Non-Muscle Invasive Bladder Cancer Clinical Studyon September 4, 2019 at 4:06 am
the first patient has been treated in its Phase II clinical study titled “A Phase II Clinical Study of Intravesical Photodynamic Therapy (“PDT”) in Patients with Bacillus Calmette Guérin (“BCG”) ...
- Biofrontera: A Small European Biotech With Interesting Value Propositionon September 4, 2019 at 2:50 am
Biofrontera is cementing a place in the photodynamic therapy market. Expanding approved product in high potential indications. Operating breakeven expected by 4Q-2019. Biofrontera AG (BFRA ...
- Effects of Photodynamic Therapy with Redaporfin on Tumor Oxygenation and Blood Flow in a Lung Cancer Mouse Modelon September 2, 2019 at 2:05 am
Lung cancer is one of the most common types of malignant tumor worldwide and the leading cause of cancer-related deaths. Despite many improvements in disease diagnosis and management, chemotherapy is ...
- Violet LED light offers whitening treatment alternativeon August 28, 2019 at 12:10 am
Violet LED light was effective, especially in combination with carbamide peroxide, they reported in Photodiagnosis and Photodynamic Therapy (August 22, 2019). Teeth whitening is one of the most sought ...
- Global Drug-Device Combination Products Market is projected to reach at a CAGR 6.9% Forecast by 2025on August 23, 2019 at 11:42 am
Aug 23, 2019 (KD Market Insights via COMTEX) -- A Comprehensive research study conducted by KD Market Insights on ” Drug-Device Combination Products Market by Product (Drug-eluting Stent, Infusion ...
- Swissmedic approves Ameluz® in combination with daylight photodynamic therapy in Switzerlandon August 20, 2019 at 4:58 pm
Before it's here, it's on the Bloomberg Terminal.
- Researchers in UK develop new technique to make cancer treatment more effective, affordableon August 17, 2019 at 9:36 am
Light-based or photodynamic therapy is already a clinically-approved treatment, which uses drugs that only work when exposed to light to destroy cancer cells. However, many of these drugs are ...
via Bing News